Pharmacogenomics in cancer therapy [electronic resource] / Sharon Marsh.
Material type: FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Cancer genetics: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (31 min.) : color, sound)Subject(s): Antineoplastic agents | Cancer -- Chemotherapy | Cancer -- Genetic aspects | Drugs -- Side effects | Pharmacogenomics | Antineoplastic Agents -- adverse effects | Antineoplastic Agents -- therapeutic use | Camptothecin -- analogs & derivatives | Drug-Related Side Effects and Adverse Reactions | Gene Expression Regulation, Neoplastic | Genetic Variation | Neoplasms -- drug therapy | Neoplasms -- genetics | Pharmacogenetics -- methods | Tamoxifen -- adverse effects | Tamoxifen -- pharmacokinetics | Tamoxifen -- therapeutic useOnline resources: Click here to access online | SeriesAnimated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.
Access restricted to subscribers.
Mode of access: World Wide Web.